In 2010, the antihypertensive drug market amounted to more than 2 billion Euros - around 10% of the total retail market. Between 1980 and 2010, this market underwent annual average growth of +5,2%. The purpose of this article is to analyse how use of antihypertensive drugs developed in France over a longitudinal period of 30 years. This analysis will attempt to break down the development of antihypertensive drug expenditure, by highlighting the impact of price, quantity and consumption patterns. Findings reveal a price reduction trend that is offset by a significant increase in volume, which includes substantial changes to consumption patterns of antihypertensive drugs. A parallel can be drawn between the trends thus observed and the different regulation mechanisms relating to pharmaceutical expenditure over the period in question.
Abstract
English
Authors
Marie-Émilie
Clerc
Blandine
Juillard-Condat
Renaud
Legal
Willy Thao
Khamsing
- Uploaded on Cairn-int.info on 30/11/-0001
Cite
Distribution électronique Cairn.info pour La Doc. française © La Doc. française. Tous droits réservés pour tous pays. Il est interdit, sauf accord préalable et écrit de l’éditeur, de reproduire (notamment par photocopie) partiellement ou totalement le présent article, de le stocker dans une banque de données ou de le communiquer au public sous quelque forme et de quelque manière que ce soit.